George Elston

Companies

• EyePoint PharmaceuticalsChief financial officer Nov 18, 2019 to now¹
• Celldex TherapeuticsBoard member Mar 17, 2008 to Jun 9, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• EPEyePoint Pharmaceuticals EYPT97,470 shares³$41.1K at $0.42Aug 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 20, 2026Gift 64,953 shares of EyePoint Pharmaceuticals³
• Aug 20, 2026Gift 64,953 shares of EyePoint Pharmaceuticals³
• Aug 20, 2026Other 5,000 shares of EyePoint Pharmaceuticals³
• Aug 20, 2026Other 5,000 shares of EyePoint Pharmaceuticals³
• May 25, 2026Shares withheld for tax 3,627 shares at $12.93 of EyePoint Pharmaceuticals⁴
• May 25, 2026Exercised options 7,500 shares of EyePoint Pharmaceuticals⁴
• Mar 2, 2026Gift 5,000 shares of EyePoint Pharmaceuticals⁵
• Mar 2, 2026Gift 5,000 shares of EyePoint Pharmaceuticals⁵
• Jan 6, 2026Shares withheld for tax 4,487 shares at $16.86 of EyePoint Pharmaceuticals⁶
• Jan 6, 2026Exercised options 15,285 shares of EyePoint Pharmaceuticals⁶
• Jan 5, 2026Shares withheld for tax 4,403 shares at $17.43 of EyePoint Pharmaceuticals⁷
• Jan 5, 2026Exercised options 15,000 shares of EyePoint Pharmaceuticals⁷
• Jan 3, 2026Shares withheld for tax 6,324 shares at $17.48 of EyePoint Pharmaceuticals⁷
• Jan 3, 2026Exercised options 19,667 shares of EyePoint Pharmaceuticals⁷
• Dec 19, 2025Gift 5,000 shares of EyePoint Pharmaceuticals⁸
• Dec 19, 2025Gift 5,000 shares of EyePoint Pharmaceuticals⁸
• Sep 19, 2025Gift 20,000 shares of EyePoint Pharmaceuticals⁹
• Sep 19, 2025Gift 20,000 shares of EyePoint Pharmaceuticals⁹
• May 25, 2025Shares withheld for tax 2,202 shares at $5.68 of EyePoint Pharmaceuticals¹⁰
• May 25, 2025Exercised options 7,500 shares of EyePoint Pharmaceuticals¹⁰
• Feb 9, 2025Exercised options 5,834 shares of EyePoint Pharmaceuticals¹¹
• Jan 6, 2025Shares withheld for tax 4,808 shares at $8.68 of EyePoint Pharmaceuticals¹²
• Jan 6, 2025Exercised options 15,285 shares of EyePoint Pharmaceuticals¹²
• Jan 5, 2025Shares withheld for tax 5,267 shares at $8.26 of EyePoint Pharmaceuticals¹²
• Jan 5, 2025Exercised options 15,000 shares of EyePoint Pharmaceuticals¹²